Immutep Ltd has released a press release.
Entitlement Offer Results & Shortfall Notification
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Immutep
- Immutep Entitlement Offer Booklet
- Immutep completes recruitment of AIPAC trial in MBC
- Immutep granted Australian patent for eftilagimod alpha
- Immutep completes recruitment of initial NSCLC cohort
- First patient dosed in INSIGHT-004
Later from Immutep
- Appendix 4E & 2019 Full Year Statutory Accounts
- Immutep granted European patent for IMP321 in cancer
- Japanese patent granted for LAG525 antibody
- Immutep to receive GBP4M Milestone Payment from GSK
- Immutep expands Part A of TACTI-002 due to positive data
Follow Immutep into a list and get an email when it puts out news.
Follow Immutep